Biotech Startups

Biohm is a research and development company developing scalable biotechnologies aimed at reshaping industrial and economic systems. Its work centers on aligning natural and cultural systems around the concept of "biosynergy," the interconnection of all living things.

1 investor

A supplier of natural cosmetic ingredients derived from 100% natural Amazonian rainforest fruits, producing raw materials for skin and hair care. It sells to the cosmetics industry, offering ingredients rich in fatty acids, active compounds, and micronutrients such as vitamins A, E, F, C and linoleic acid.

1 investor

Biointaxis is an academic biotech spin-off developing a gene therapy to restore the function of a defective protein in patients with Friedreich's ataxia, a rare inherited neurodegenerative disease. The company handles early-stage R&D, pre-clinical, and early clinical (Phase I/II) development, aiming to license production and distribution rights to pharmaceutical partners.

1 investor

Unable to determine company business from page content. The page appears to be an investor relations contact page in Chinese for a company with headquarters in Shenzhen.

1 investor

BioKine develops immunotherapy drug candidates targeting cancer metastasis and treatment resistance, with its lead product BL-8040 in multiple clinical trials including stem cell mobilization, acute myeloid leukemia, and pancreatic carcinoma.

1 investor

Biokorf works on 3D Integrated Pharmaceuticals, including particle engineering and cocrystals for drug development.

1 investor

BioLamina develops full-length human recombinant laminin proteins and related cell culture substrates for research and clinical applications. The company's products support the growth and differentiation of pluripotent stem cells, tissue-specific cells, and organoid development in both 2D and 3D culture environments.

1 investor

BioLoom is a configurable robotic bioprinting platform for multi-material biofabrication, combining MEW, DIW, MEX, and FDM in a single build with dual independent IDEX turrets, a sealed GMP-ready chamber, and computer-vision monitoring. It serves biotech and tissue-engineering researchers for fabricating human-relevant tissue constructs, organoids, and scaffolds for drug screening and regulated manufacturing.

1 investor

BioLife Solutions develops biopreservation media, cryopreservation tools, storage systems, and closed-system cell processing solutions for cell and gene therapy manufacturing. It serves bioprocess engineers, therapy developers, and contract development and manufacturing organizations (CDMOs), with regulatory support for GMP, FDA, and EMA compliance.

1 investor

Biolinco provides a platform for cell line development that uses DNA barcoding and multi-omic characterization to help biopharmaceutical companies evaluate and select optimal cell clones. The platform addresses limitations in traditional workflows that evaluate only a small number of clones.

1 investor

Bioline Rx develops therapies for patients with cancer and rare diseases, leveraging a team with expertise spanning drug development from chemistry through clinical trials to commercialization.

1 investor

BioLink is a biotechnology company that develops and manufactures process equipment and consumables for life science applications, including recombinant protein drugs, vaccines, antibody drugs, cell therapy, and gene therapy production. The company supplies upstream cell culture, disposable storage and downstream chromatography, filtration, and hydration products along with process development services.

1 investor

BioLM provides AI/ML solutions for protein and DNA analysis, serving researchers and scientists in the biotechnology and synthetic biology sectors with tailored models and APIs.

1 investor

Biologic Input Output Systems develops neural interface technology to restore natural movement and sensation for individuals with limb loss, enabling intuitive control of prosthetic limbs through direct brain-machine connections.

1 investor

Biologos is a GMP-certified manufacturer of custom cell culture media, buffers, and reagents for biopharmaceutical and research customers. The company specializes in rapid formulation and aseptic manufacturing of biologics-related products to support disease treatment and prevention efforts.

1 investor

Biolyst supplies tools, products, and consulting services to clinicians and research scientists advancing discovery in the life sciences. The company specializes in supporting laboratory and clinical workflows through comprehensive product portfolios and strategic partnerships with healthcare and research institutions.

1 investor

Biolytx Pharmaceuticals is developing a novel antibiotic peptide, currently in pre-clinical trials, to treat serious hospital-acquired infections including those resistant to existing antibiotics. It operates in the biotechnology and pharmaceutical drug development sector.

1 investor

BioMarin is a biotechnology company that develops medicines derived from genetic discoveries to treat serious and rare diseases. Founded in 1997, it markets nine commercial therapies and maintains a clinical and preclinical drug development pipeline.

1 investor

1 investor

Biomarx develops automated liquid biopsy diagnostics using biosensing technologies for early cancer and disease detection, delivering test results in under two hours at low cost. Its products target clinicians and healthcare providers seeking rapid, affordable precision diagnostics for personalised medicine.

1 investor

Biomatlante (Advanced Medical Solutions, Nantes) develops synthetic bone graft matrices for bone regeneration, used by surgeons in orthopedics, trauma, spine, and dental surgery. Based near Nantes, France, it sells its bone graft products in over 50 countries.

1 investor

Biome Makers is an AgTech company that uses DNA sequencing and its BeCrop technology to analyze soil microbiome data and deliver soil health intelligence for yield limitations, disease diagnosis, and input product evaluation. It serves farmers, agronomic advisors and retailers, ag input manufacturers, and food and beverage companies worldwide.

1 investor

Biome Resources develops Kronobiotic, a supplement designed to balance intestinal microbiota. The company offers health-focused products sold through online channels.

1 investor

Biomea Fusion is a clinical-stage company developing oral small-molecule drugs for diabetes, obesity, and metabolic diseases, with lead programs including icovamenib, a menin inhibitor, and BMF-650, a GLP-1 receptor agonist.

1 investor